Clinical trials (with both medicines and medicinal products).
Independent sponsor.
Multicenter projects (as part of a network).

• A sponsor can be a university, hospital, public scientific organization, non-profit organization, patient association, or individual investigator.
• The research data are the sponsor’s property from the start of the study.
• There are no agreements between the sponsor and third parties that allow for the use of data for regulatory uses or for uses that generate industrial property.
• The design, conduct, recruitment, data collection, and communication of research results are under the control of the sponsor.
• Given their characteristics, these studies cannot form part of a development program for the marketing authorization of product.

Any researcher from the Regional University Hospitals or Virgen de la Victoria Hospital in Malaga, Primary Care, or translational groups from the University of Malaga (UMA) can request assistance related to the design, implementation, and conduct of independent clinical trials in accordance with the wide range of services offered by UICEC-IBIMA. These services include methodological support, CRD preparation, contract management, procedures with competent authorities, pharmacovigilance, pre-initiation, initiation visits, periodic monitoring visits, and clinical trial closure.

Farmaindustria – Excellence criterio for conducting clinical trials